ArticleTranslational cancer research2025
Clinical efficacy and safety of pyrotinib as the first-line treatment of HER2-positive advanced breast cancer in Xinjiang Uygur Autonomous Region of China.
Qi Xiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.